186 related articles for article (PubMed ID: 17239513)
1. Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology.
Lacerda AL; Hardan AY; Yorbik O; Vemulapalli M; Prasad KM; Keshavan MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):510-6. PubMed ID: 17239513
[TBL] [Abstract][Full Text] [Related]
2. Volume reduction and altered sulco-gyral pattern of the orbitofrontal cortex in first-episode schizophrenia.
Takayanagi Y; Takahashi T; Orikabe L; Masuda N; Mozue Y; Nakamura K; Kawasaki Y; Itokawa M; Sato Y; Yamasue H; Kasai K; Okazaki Y; Suzuki M
Schizophr Res; 2010 Aug; 121(1-3):55-65. PubMed ID: 20605415
[TBL] [Abstract][Full Text] [Related]
3. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
[TBL] [Abstract][Full Text] [Related]
4. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia.
van Veelen NM; Vink M; Ramsey NF; Kahn RS
Schizophr Res; 2010 Oct; 123(1):22-9. PubMed ID: 20724113
[TBL] [Abstract][Full Text] [Related]
5. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder.
Lacerda AL; Keshavan MS; Hardan AY; Yorbik O; Brambilla P; Sassi RB; Nicoletti M; Mallinger AG; Frank E; Kupfer DJ; Soares JC
Biol Psychiatry; 2004 Feb; 55(4):353-8. PubMed ID: 14960287
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
8. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.
Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E
Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418
[TBL] [Abstract][Full Text] [Related]
9. Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
Hoptman MJ; Volavka J; Weiss EM; Czobor P; Szeszko PR; Gerig G; Chakos M; Blocher J; Citrome LL; Lindenmayer JP; Sheitman B; Lieberman JA; Bilder RM
Psychiatry Res; 2005 Nov; 140(2):133-45. PubMed ID: 16253482
[TBL] [Abstract][Full Text] [Related]
10. Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study.
Shad MU; Muddasani S; Keshavan MS
Psychiatry Res; 2006 Jan; 146(1):35-42. PubMed ID: 16361089
[TBL] [Abstract][Full Text] [Related]
11. Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum.
Kirschner M; Schmidt A; Hodzic-Santor B; Burrer A; Manoliu A; Zeighami Y; Yau Y; Abbasi N; Maatz A; Habermeyer B; Abivardi A; Avram M; Brandl F; Sorg C; Homan P; Riecher-Rössler A; Borgwardt S; Seifritz E; Dagher A; Kaiser S
Schizophr Bull; 2021 Apr; 47(3):849-863. PubMed ID: 33257954
[TBL] [Abstract][Full Text] [Related]
12. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
14. Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients.
Kasparek T; Prikryl R; Schwarz D; Kucerova H; Marecek R; Mikl M; Vanicek J; Ceskova E
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1438-46. PubMed ID: 19647777
[TBL] [Abstract][Full Text] [Related]
15. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
16. Aberrant intrinsic brain activity and cognitive deficit in first-episode treatment-naive patients with schizophrenia.
He Z; Deng W; Li M; Chen Z; Jiang L; Wang Q; Huang C; Collier DA; Gong Q; Ma X; Zhang N; Li T
Psychol Med; 2013 Apr; 43(4):769-80. PubMed ID: 22883428
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia.
van Veelen NM; Vink M; Ramsey NF; van Buuren M; Hoogendam JM; Kahn RS
Schizophr Res; 2011 Jul; 129(2-3):156-62. PubMed ID: 21497488
[TBL] [Abstract][Full Text] [Related]
18. Reduced paralimbic system gray matter volume in schizophrenia: Correlations with clinical variables, symptomatology and cognitive function.
Liao J; Yan H; Liu Q; Yan J; Zhang L; Jiang S; Zhang X; Dong Z; Yang W; Cai L; Guo H; Wang Y; Li Z; Tian L; Zhang D; Wang F
J Psychiatr Res; 2015 Jun; 65():80-6. PubMed ID: 25937503
[TBL] [Abstract][Full Text] [Related]
19. Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study.
Nery FG; Chen HH; Hatch JP; Nicoletti MA; Brambilla P; Sassi RB; Mallinger AG; Keshavan MS; Soares JC
Bipolar Disord; 2009 Mar; 11(2):145-53. PubMed ID: 19267697
[TBL] [Abstract][Full Text] [Related]
20. The relationship between prefrontal brain volume and characteristics of memory strategy in schizophrenia spectrum disorders.
Matsui M; Suzuki M; Zhou SY; Takahashi T; Kawasaki Y; Yuuki H; Kato K; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1854-62. PubMed ID: 18796324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
